Cardiovascular CNS Company Showcase Endocrine Musculoskeletal system and connective tissue Oncology Pharma Phase III


Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Cipla’s API pipeline consists of 75+ complex developments in the therapy areas of Oncology, Hep C, ARV, Diabetology, CVS, CNS, Respiratory etc. In 2019, its market capitalization was $7.5 billion in US dollars.

Cipla Limited是一家印度跨国制药和生物技术公司,总部位于印度孟买。 Cipla主要开发药物以治疗心血管疾病、关节炎、糖尿病、肥胖症及抑郁等,以及其他医疗状况。公司的API pipeline包括肿瘤,肝C,抗逆转录病毒,糖尿病,CVS,中枢神经系统,呼吸系统等治疗领域的超过75种复杂的药物开发。截止2019年,公司市值为75亿美元。

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s